MLICM
RLYB icon

Metropolitan Life Insurance Company (MetLife)’s Rallybio RLYB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-220
Closed -$5.93K – 2381
2023
Q3 		$5.93K Hold
220
– – ﹤0.01% 2384
2023
Q2 		$9.96K Buy
+220
New +$10.8K ﹤0.01% 2304
2023
Q1 		– Sell
-165
Closed -$8.66K – 2437
2022
Q4 		$8.66K Buy
165
+19
+13% +$1.12K ﹤0.01% 2317
2022
Q3 		$16.9K Buy
+146
New +$13K ﹤0.01% 2102

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RLYB Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Rallybio (RLYB) in Q4 2023, closing a stake of 220 shares — an estimated $5.93K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RLYB in Q3 2022 and held it in 4 quarters. The position peaked at $16.9K in Q3 2022. 54 funds tracked by Wall St. Rank hold RLYB as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Rallybio position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 220 Rallybio shares in Q4 2023, an estimated $5.93K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Rallybio in Q3 2022 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Rallybio position peaked at $16.9K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Rallybio as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.